False positivity of FDG-PET/CT in a child with Hodgkin disease

Dildar Bahar Beker, Su Gulsun Berrak, Cengiz Canpolat, Halil Tugtepe, Tunc Ones, Tulay Tecimer

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Role of Positron Emission Tomography (PET) with F-18-2-fluoro-2-deoxy-D- glucose (FDG) in staging of Hodgkin disease is well established despite several controversies. We report a Stage III Hodgkin lymphoma patient with false positive FDG-PET/CT results. Seven-year-old male with Hodgkin lymphoma was in remission at end of chemotherapy. At third and fourth months of postchemotherapy follow-up, increased gallium uptake and positive FDG-PET/CT in right lower quadrant of abdomen was observed. Open biopsy revealed lymphoid hyperplasia. He has been followed for 21 months without any evidence of disease. Despite its documented benefit, we believe that results of FDG-PET/CT should be interpreted with great caution in order to avoid unnecessary interventions.

Original languageEnglish (US)
Pages (from-to)881-883
Number of pages3
JournalPediatric Blood and Cancer
Issue number4
StatePublished - Apr 1 2008


  • False positivity
  • Hodgkin
  • Lymphoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'False positivity of FDG-PET/CT in a child with Hodgkin disease'. Together they form a unique fingerprint.

Cite this